Moderna wants the FDA to authorize its COVID-19 vaccine for kids under six. Here's what's next in the process. | via NPR
A Moderna COVID-19 vaccine is prepared during a pop-up vaccine clinic at Cristo Rey Church in East Austin on July 24, 2021.
"Given the need for a vaccine against COVID-19 in infants and young children, we are working with the U.S. FDA and regulators globally to submit these data as soon as possible," Moderna CEO Stéphane BancelIn tests, the doses were given 28 days apart to 2,500 children ages 6 months to under 2 and to 4,200 children ages 2 to under 6.
Dr. Jesse Goodman, a professor of medicine and infectious diseases at Georgetown University, said the study, while promising, leaves many questions unanswered, such as how long the children were observed after being vaccinated and whether efficacy rates could decline over time. 17% of children from 6 months to under 2 years old had fevers of 100.4 degrees, while 14.6% of children from 2 to under 6 had the same side effect. These results are"consistent with other commonly used and recommended pediatric vaccines," the release said.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Moderna wants the FDA to authorize its COVID-19 vaccine for kids under 6The company will submit a request to the Food and Drug Administration “in the coming weeks” for authorization for a two-dose shot for younger kids.
Read more »
Moderna wants the FDA to authorize its COVID-19 vaccine for kids under 6 - Alaska Public MediaModerna is hoping to get the green light to administer a pediatric, low-dose COVID-19 vaccine for children ages 6 months to under 6 years of age.
Read more »
FDA reveals details about what went wrong with baby formula linked to infant deathsAbbott didn’t maintain clean surfaces used in producing and handling the powdered formula, according to the FDA inspection, which concluded last week.
Read more »
FDA details problems at plant behind recalled baby formulaBaby formula maker Abbott failed to maintain sanitary conditions and procedures at the Michigan manufacturing plant recently linked to a cluster of infant illnesses, according to findings released by federal safety inspectors.
Read more »
FDA details problems at plant behind recalled baby formulaAmong other problems, FDA inspectors found a history of contamination with the bacteria, known as cronobacter, in various parts of the plant.
Read more »
FDA probe of Abbott facility finds quality control issuesAn inspection at the Abbott Laboratories facility in Sturgis, Michigan found a harmful bacteria on surfaces in some areas of its powdered baby formula production, the U.S. health regulator said on Tuesday.
Read more »